- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- Medin-N LLC
Medin-N LLC
Medin-N LLC is an actively developing enterprise, a recognized leader in the production of surgical needles and sutures in Russia. Since 1992, the company has been supplying surgical suture material to all regions of Russia and neighboring countries. Medin-N LLC offers more than two thousand combinations of absorbable and non-absorbable surgical sutures with atraumatic needles of various lengths and diameters: round, triangular, quadrangular, spatula-shaped, with conical sharpening and grooves.
The specialists of Medin- N LLC, together with the Postovsky Institute of Organic Synthesis, Ural branch of the Russian Academy of Sciences, have organized the only chemical production of absorbable polymer materials in Russia based on their own patented technologies. The company sells absorbable surgical products of its own manufacture: braided surgical sutures Sabfil and Sabfil Plus based on the polyglycolic and polylactic acids, absorbable monofilaments based on polydioxanone «Sabmon», absorbable monofilaments Soft Lift based on a copolymer of the lactic acid and ε- Caprolactone with notches for cosmetology, absorbable screws and pins for osteosynthesis. Polymer materials produced by Medin-N LLC are used by Leypunsky Institute of Physics and Power Engineering (IPPE) in the manufacture of absorbable strands for brachytherapy of prostate cancer. In close cooperation with health care institutions, the company is continuously developing import-substituting and innovative surgical products.
Medin-N LLC also produces a line of medical products: a set for infusion into the small veins of newborns, an endoloop for laparoscopic operations, needles for transvaginal follicle puncture, sets for vitrification of embryos/oocytes. The production of calcium phosphate materials for the replacement of bone tissue defects has been organized.
23A, Artinskaya St., Ekaterinburg
Tel.: (343) 212-58-82, 212-72-59
E-mail: sale@medin-n.ru
